Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: MiNK Therapeutics(INKT) the EBIT is -3.217 M (+20.62%), Miss estimate;the EPS is -0.62 (+41.51%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.00B20.62%
-0.00B25.97%
-0.00B5.35%
EPSMiss expectations
-0.6241.51%
-0.643.40%
-0.02001.89%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf